Detrimental effect of broad-spectrum antibiotics on intestinal microbiome diversity in patients after allogeneic stem cell transplantation: lack of commensal sparing antibiotics.
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Maintaining gastrointestinal (GI) microbiome diversity plays a key role during allogeneic stem cell transplantation (ASCT), and loss of diversity correlates with acute GI graft versus host disease (GvHD) and poor outcomes. METHODS: In this retrospective analysis of 161 ASCT patients, we used serial analyses of urinary 3-indoxyl sulfate (3-IS) levels and GI microbiome parameters within the first 10 days after ASCT to identify potential commensal microbiota-sparing antibiotics. Based on antibiotic activity, we formed 3 subgroups (Rifaximin without systemic antibiotics, Rifaximin with systemic antibiotics, and Ciprofloxacin/Metronidazole with/without systemic antibiotics). RESULTS: Mono-antibiosis with Rifaximin revealed higher 3-IS levels (P < .001), higher Clostridium cluster XIVa (CCXIVa) abundance (P = .004), and higher Shannon indices (P = .01) compared to Ciprofloxacin/Metronidazole with/without systemic antibiotics. Rifaximin followed by systemic antibiotics maintained microbiome diversity compared to Ciprofloxacin/Metronidazole with/without systemic antibiotics, as these patients showed still higher 3-IS levels (P = .04), higher CCXIVa copy numbers (P = .01), and higher Shannon indexes (P = .01). Even for this larger cohort of patients, the outcome was superior with regard to GI GvHD (P = .05) and lower transplant-related mortality (P < .001) for patients receiving Rifaximin plus systemic antibiotics compared to other types of systemic antibiotic treatment. Antibiosis with Ciprofloxacin/Metronidazole (n = 12, P = .01), Piperacillin/Tazobactam (n = 52, P = .01), Meropenem/Vancomycin (n = 16, P = .003), Ceftazidime (n = 10, P = .03), or multiple systemic antibiotics (n = 53, P = .001) showed significantly lower 3-IS levels compared to mono-antibiosis with Rifaximin (n = 14) or intravenous Vancomycin (n = 4, not statistically significant). CONCLUSIONS: Different types of antibiotic treatments show different impacts on markers of microbiome diversity. The identification of antibiotics sparing commensal bacteria remains an ongoing challenge. However, Rifaximin allowed a higher intestinal microbiome diversity, even in the presence of systemic broad-spectrum antibiotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Exposure to broad-spectrum antibiotic (ATB) therapy may adversely influence outcomes of ICI therapy 2 through modulation of intestinal microbiota, 3 a key host determinant of response to ICIs known to precondition cancer-specific immunity.4”
From Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer (2019) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Mathematical Theory of Communication
Shannon, C. E. (1948) · Bell System Technical Journal · doi:10.1002/j.1538-7305.1948.tb01338.x · Cited by 88,486
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Search and clustering orders of magnitude faster than BLAST
Edgar, R. C. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq461 · Cited by 20,826
VSEARCH: a versatile open source tool for metagenomics
(2016) · doi:10.7717/peerj.2584 · Cited by 10,773
Pruesse, E., Quast, C., Knittel, K., Fuchs, B. M., Ludwig, W., Peplies, J., & Glockner, F. O. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm864 · Cited by 6,668
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J. R., Pfeffer, K., Coffer, P. J., et al. (2013) · Nature · doi:10.1038/nature12726 · Cited by 4,838
Introduction to the human gut microbiota
Thursby, E., & Juge, N. (2017) · Biochemical Journal · doi:10.1042/bcj20160510 · Cited by 3,600
The human microbiome: at the interface of health and disease
Cho, I., & Blaser, M. J. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3182 · Cited by 3,449
Mathematical Theory of Communication
(2009) · Encyclopedia of Neuroscience · doi:10.1007/978-3-540-29678-2_3338 · Cited by 2,297
Microbes in Gastrointestinal Health and Disease
Neish, A. S. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.10.080 · Cited by 1,386
Cited by
Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation
Peled, J. U., Gomes, A. L. C., Devlin, S. M., Littmann, E. R., Taur, Y., Sung, A. D., Weber, D., Hashimoto, D., Slingerland, A. E., Slingerland, J. B., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1900623 · Cited by 765
Pinato, D. J., Howlett, S., Ottaviani, D., Urus, H., Patel, A., Mineo, T., Brock, C., Power, D., Hatcher, O., Falconer, A., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.2785 · Cited by 626
Münch, N. S., Fang, H., Ingermann, J., Maurer, H. C., Anand, A., Kellner, V., Sahm, V., Wiethaler, M., Baumeister, T., Wein, F., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.04.013 · Cited by 168
Jing, Y., Chen, X., Li, K., Liu, Y., Zhang, Z., Chen, Y., Liu, Y., Wang, Y., Lin, S. H., Diao, L., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003779 · Cited by 129
Ingham, A. C., Kielsen, K., Cilieborg, M. S., Lund, O., Holmes, S., Aarestrup, F. M., Müller, K., & Pamp, S. J. (2019) · Microbiome · doi:10.1186/s40168-019-0745-z · Cited by 128
Ingham, A. C., Kielsen, K., Mordhorst, H., Ifversen, M., Aarestrup, F. M., Müller, K., & Pamp, S. J. (2021) · Microbiome · doi:10.1186/s40168-021-01100-2 · Cited by 105
Gut Microbiota Influence in Hematological Malignancies: From Genesis to Cure
Uribe‐Herranz, M., Klein-González, N., Rodríguez‐Lobato, L. G., Juan, M., & de Larrea, C. F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031026 · Cited by 88
Morjaria, S. M., Schlüter, J., Taylor, B. P., Littmann, E. R., Carter, R. A., Fontana, E., Peled, J. U., van den Brink, M. R. M., Xavier, J. B., & Taur, Y. (2019) · Infection and Immunity · doi:10.1128/iai.00206-19 · Cited by 85
Ilett, E. E., Jørgensen, M., Noguera-Julian, M., Nørgaard, J. C., Daugaard, G., Helleberg, M., Paredes, R., Murray, D. D., Lundgren, J., MacPherson, C., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020002677 · Cited by 74
Roles of the intestinal microbiota and microbial metabolites in acute GVHD
Lin, D., Hu, B., Li, P., Zhao, Y., Xu, Y., & Wu, D. (2021) · Experimental Hematology & Oncology · doi:10.1186/s40164-021-00240-3 · Cited by 71
Dutta, D., & Lim, S. H. (2020) · Biomarker Research · doi:10.1186/s40364-020-00211-6 · Cited by 64
Allogeneic hematopoietic cell transplantation, the microbiome, and graft-versus-host disease
van Lier, Y. F., Vos, J., Blom, B., & Hazenberg, M. D. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2178805 · Cited by 69
UEDA, K., YONEKURA, S., OGASAWARA, N., MATSUNAGA, Y., HOSHINO, R., KUROSE, H., CHIKUI, K., UEMURA, K., NAKIRI, M., NISHIHARA, K., et al. (2019) · Anticancer Research · doi:10.21873/anticanres.13836 · Cited by 48
Gut dysbiosis during antileukemia chemotherapy versus allogeneic hematopoietic cell transplantation
Rashidi, A., Kaiser, T., Graiziger, C. T., Holtan, S. G., Rehman, T. U., Weisdorf, D. J., Dunny, G. M., Khoruts, A., & Staley, C. M. (2019) · Cancer · doi:10.1002/cncr.32641 · Cited by 51
Köhler, N., & Zeiser, R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03179 · Cited by 52
Rashidi, A., Gao, F., Fredricks, D. N., Pergam, S. A., Mielcarek, M. B., Milano, F., Sandmaier, B. M., & Lee, S. J. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.17188 · Cited by 46
Gut microbiota, microbiota‐derived metabolites, and graft‐versus‐host disease
Yue, X., Zhou, H., Wang, S., Chen, X., & Xiao, H. (2024) · Cancer Medicine · doi:10.1002/cam4.6799 · Cited by 46
Rattanathammethee, T., Tuitemwong, P., Thiennimitr, P., Sarichai, P., Pombejra, S. N., Piriyakhuntorn, P., Hantrakool, S., Chai‐Adisaksopha, C., Rattarittamrong, E., Tantiworawit, A., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0236460 · Cited by 45
Meedt, E., Hiergeist, A., Gessner, A., Dettmer, K., Liebisch, G., Ghimire, S., Poeck, H., Edinger, M., Wolff, D., Herr, W., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab500 · Cited by 46
Muratore, E., Leardini, D., Baccelli, F., Venturelli, F., Prete, A., & Masetti, R. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.993668 · Cited by 41
Orberg, E. T., Meedt, E., Hiergeist, A., Xue, J., Heinrich, P., Ru, J., Ghimire, S., Miltiadous, O., Lindner, S., Tiefgraber, M., et al. (2024) · Nature Cancer · doi:10.1038/s43018-023-00669-x · Cited by 49
Gavriilaki, M., Sakellari, I., Anagnostopoulos, Α., & Gavriilaki, E. (2020) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2020.05.011 · Cited by 42
Potential of Fecal Microbiota Transplantation to Prevent Acute GVHD: Analysis from a Phase II Trial
Rashidi, A., Ebadi, M., Rehman, T. U., Elhusseini, H., Kazadi, D., Halaweish, H., Khan, M. H., Hoeschen, A. L., Cao, Q., Luo, X., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-2369 · Cited by 38
Henig, I. J., Yehudai‐Ofir, D., & Zuckerman, T. (2020) · Haematologica · doi:10.3324/haematol.2020.247395 · Cited by 41
Sprockett, D. D., Fischer, N., Boneh, R. S., Turner, D., Kierkus, J., Sładek, M., Escher, J. C., Wine, E., Yerushalmi, B., Dias, J. A., et al. (2019) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izz130 · Cited by 33
Mucositis and Infection in Hematology Patients
Blijlevens, N. M. A., & de Mooij, C. E. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119592 · Cited by 32
Zhang, L., Bai, L., Liu, X., Liu, Y., Li, S., Liu, J., Zhang, S., Yang, C., Ren, X., & Cheng, Y. (2020) · Thoracic Cancer · doi:10.1111/1759-7714.13370 · Cited by 25
Innao, V., Allegra, A. G., Musolino, C., & Allegra, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238902 · Cited by 37
Antimicrobial therapy during cancer treatment: Beyond antibacterial effects
Ghanem, S., Kim, C. J., Dutta, D., Salifu, M. O., & Lim, S. H. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13238 · Cited by 27
Chain, C., Sheehan, J. P., Xu, X., Ghaffari, S., Godbole, A., Kim, H., Freundlich, J. S., Rabinowitz, J. D., & Gitai, Z. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01665-2 · Cited by 23
Fujiwara, H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.703298 · Cited by 27
Pak, S., Kim, S., Kim, S. H., Joung, J. Y., Park, W. S., Chung, J., Lee, K. H., & Seo, H. K. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.570077 · Cited by 22
Recent advances in neutropenic enterocolitis: Insights into the role of gut microbiota
Kapandji, N., Azoulay, É., & Zafrani, L. (2022) · Blood Reviews · doi:10.1016/j.blre.2022.100944 · Cited by 26
Weber, D., Hiergeist, A., Weber, M., Ghimire, S., Salzberger, B., Wolff, D., Poeck, H., Gessner, A., Edinger, M., Herr, W., et al. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad389 · Cited by 24
Pianko, M. J., & Golob, J. L. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10033-7 · Cited by 23
Göttert, S., Orberg, E. T., Fan, K., Heinrich, P., Matthe, D. M., Khalid, O., Klostermeier, L., Suriano, C., Strieder, N., Gebhard, C., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-65180-6 · Cited by 24
Gu, Z.-Y., Xiong, Q., Wang, L., Wang, L., Li, F., Hou, C., Dou, L., Zhu, B., & Liu, D. (2022) · Cancer · doi:10.1002/cncr.34091 · Cited by 19
Habibi, S., & Rashidi, A. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2229567 · Cited by 19
Ghimire, S., Weber, D., Hippe, K., Meedt, E., Hoepting, M., Kattner, A.-S., Hiergeist, A., Gessner, A., Matos, C., Ghimire, S., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.753287 · Cited by 17
Daoud-Asfour, H., Henig, I. J., Ghersin, I., Rakedzon, S., Stern, A., Pitashny, M., Zuckerman, T., & Bar‐Yoseph, H. (2021) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2021.12.012 · Cited by 22
The role of fecal microbiota transplantation in the treatment of acute graft-versus-host disease
Guo, Z., He, M., Shao, L., Li, Y., Xiang, X., & Wang, Q. (2024) · Journal of Cancer Research and Therapeutics · doi:10.4103/jcrt.jcrt_33_24 · Cited by 15
Host and Graft Factors Impacting Infection Risk in Hematopoietic Cell Transplantation
Kao, R. L., & Holtan, S. G. (2019) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2019.02.001 · Cited by 18
The Microbiome and Its Impact on Allogeneic Hematopoietic Cell Transplantation
Malard, F., & Jenq, R. R. (2023) · The Cancer Journal · doi:10.1097/ppo.0000000000000645 · Cited by 15
Wang, D., Xu, L., Liu, Y., Wang, C., Qi, S., Li, Z., Bai, X., Liao, Y., & Wang, Y.-C. (2024) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2024.5416 · Cited by 16
Altered intestinal microbiome and epithelial damage aggravate intestinal graft-versus-host disease
Gao, F., Wu, H., Wang, L., Zhao, Y., & Huang, H. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2221821 · Cited by 13
A contemporary review of Clostridioides difficile infections in patients with haematologic diseases
Dutta, D., Jafri, F. M., STUHR, D., Knoll, B. M., & Lim, S. H. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13173 · Cited by 15
Han, L., Zhang, H., Ma, P., Peng, J., Li, Y., Wu, J., Li, Y., Yu, J., Li, W., Zhang, M., et al. (2022) · Annals of Hematology · doi:10.1007/s00277-022-04817-8 · Cited by 11
Hamilton, B. K., Rybicki, L. A., Grove, D., Ferraro, C. S., Starn, J., Hodgeman, B., Elberson, J., Winslow, V. A., Corrigan, D., Gerds, A. T., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000345 · Cited by 9
Jessica Thomas, M., Christi Bowe, M., & Joyce E. Dains, D. (2022) · Journal of the Advanced Practitioner in Oncology · doi:10.6004/jadpro.2022.13.1.5 · Cited by 10
Nowicka, A., Tomczak, H., Szałek, E., Karbownik, A., & Gil, L. (2025) · Biomedicines · doi:10.3390/biomedicines13071761 · Cited by 9
Kaundal, S., Jandial, A., Singh, H., Chopra, M., Kasudhan, K. S., Khaire, N. S., Khadwal, A., Prakash, G., Jain, A., Suri, V., et al. (2021) · Transplant Infectious Disease · doi:10.1111/tid.13717 · Cited by 8
Sex-Biased Immune Responses to Antibiotics during Anti-PD-L1 Treatment in Mice with Colon Cancer
Jing, N., Wang, L., Zhuang, H., Ai, C., Jiang, G., & Liu, Z. (2022) · Journal of Immunology Research · doi:10.1155/2022/9202491 · Cited by 8
Effect of GVHD on the gut and intestinal microflora
Ji, H., Feng, S., Liu, Y., Cao, Y., Lou, H., & Li, Z. (2024) · Transplant Immunology · doi:10.1016/j.trim.2023.101977 · Cited by 9
Ghimire, S., Ederer, K. U., Meedt, E., Weber, D., Matos, C., Hiergeist, A., Zeman, F., Wolff, D., Edinger, M., Poeck, H., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.857400 · Cited by 7
Chiu, C., Lei, K. F., Chan, Y., Ueng, S. W., & Chen, A. C. (2019) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-019-2705-y · Cited by 7
Akhmedov, M., & Espinoza, J. L. (2024) · Blood Reviews · doi:10.1016/j.blre.2024.101229 · Cited by 6
Mucosal microbiotas and their role in stem cell transplantation
Ingham, A. C., & Pamp, S. J. (2022) · Apmis · doi:10.1111/apm.13208 · Cited by 6
Faoro, L., Brusegan, A., Russi, A., Calderone, V., Martelli, A., Marranconi, E., Carpanese, D., Berti, E., & Coppola, M. (2023) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-023-00663-0 · Cited by 5
Toenges, R., Lang, F., Ghaffar, R., Lindner, S., Schlipfenbacher, V., Riemann, J., Ajib, S., Kouidri, K., Cremer, A., Bodo, W., et al. (2024) · Annals of Hematology · doi:10.1007/s00277-024-05986-4 · Cited by 4
Gürer, E. E., Meedt, E., Feicht, J., Cao, K., Hiergeist, A., Mamilos, A., Hirsch, D. D., Hoepting, M., Kattner, A.-S., Matos, C., et al. (2025) · Blood · doi:10.1182/blood.2025029402 · Cited by 4
Nakagaki, M., Hajkowicz, K. M., Roberts, J. A., & Henden, A. S. (2025) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2025.2527970 · Cited by 3
Tian, J.-X., Miao, W., Yan, H., Wang, X., Liao, Y.-X., Li, S., Jiang, E., & Zhang, P. (2023) · Annals of Translational Medicine · doi:10.21037/atm-22-6341 · Cited by 3
Incidence of bacterial blood stream infections in patients with acute GVHD
Wallis, W. D., Gulbis, A. M., Wang, T., Lee, C. J., Sharma, A., Williams, K. M., Nishihori, T., Prestidge, T. D., Gowda, L., Byrne, M. T., et al. (2024) · Bone Marrow Transplantation · doi:10.1038/s41409-024-02426-9 · Cited by 3
Can febrile neutropenia re-invent its self?
Georgala, A., & Klastersky, J. A. (2025) · Current Opinion in Oncology · doi:10.1097/cco.0000000000001116 · Cited by 3
The Role of the Gut Microbiota in Allogeneic Hematopoietic Cell Transplantation
Hao, W., Stocker, N., Gaugler, B., Mohty, M., & Malard, F. (2026) · American Journal of Hematology · doi:10.1002/ajh.70360 · Cited by 2
Role of mucositis in predicting gut microbiota composition in people with cancer
Scott, J. S., Li, A., & Wardill, H. R. (2024) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0000000000000700 · Cited by 2
Nguyen, A., Fender, J., Courjon, J., Fischer, A., Mappoura, M., Morin, S., Giannotti, F., Mamez, A., Chalandon, Y., Masouridi‐Levrat, S., et al. (2024) · Transplant Infectious Disease · doi:10.1111/tid.14375 · Cited by 2
An infectious diseases perspective on the microbiome and allogeneic stem cell transplant
Smibert, O. C., Trubiano, J. A., Slavin, M. A., & Kwong, J. C. (2020) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000683 · Cited by 2
Antimicrobial Stewardship in Immunocompromised Hosts
Vindenes, T., Melinscak, H., Linder, K. E., & Alsoubani, M. (2023) · Springer eBooks · doi:10.1007/978-3-031-21710-4_7 · Cited by 3
The distribution of intestinal flora after hematopoietic stem cell transplantation in children
Tong, L., Meng, Y., Zhang, L., Yu, J. Z., & Dou, Y. (2023) · Pediatric Transplantation · doi:10.1111/petr.14678 · Cited by 2
Low utilization of vancomycin in febrile neutropenia: real-world evidence from 4 Brazilian centers
Ramos, J. F., Pereira, A. D., Seiwald, M. C. N., Gandolpho, L. S., de Molla, V. C., Guaraná, M., Nouér, S. A., Nucci, M., & Arrais‐Rodrigues, C. (2023) · Supportive Care in Cancer · doi:10.1007/s00520-023-08152-0 · Cited by 2
Kreisinger, J., Dooley, J., Singh, K. N., Čížková, D., Schmiedová, L., Bendová, B., Liston, A., & Moudrá, A. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1324403 · Cited by 1
The intestinal microbiota as a key modulator of acute graft-versus-host disease
Paredes, J. E., Schmiester, M., Jenq, R. R., & van den Brink, M. R. M. (2026) · Nature reviews. Cancer · doi:10.1038/s41568-026-00910-6 · Cited by 3
Determinants of the Gut Microbiota
Muthaiyan, A. (2020) · Springer eBooks · doi:10.1007/978-3-030-47384-6_2 · Cited by 3
Yoshikawa, S., Taniguchi, K., Sawamura, H., Ikeda, Y., Tsuji, A., & Matsuda, S. (2023) · World Journal of Hematology · doi:10.5315/wjh.v10.i2.15 · Cited by 1
Infektionsprävention und VRE: eine unendliche Geschichte
Caplunik-Pratsch, A., Rath, A., Fritsch, J., Holzmann, T., & Schneider‐Brachert, W. (2020) · Krankenhaushygiene up2date · doi:10.1055/s-0043-118566 · Cited by 1
Andrew, E. C., Khaw, S. L., Hanna, D. T., Conyers, R. K., Fleming, J., Hughes, D., Toro, C., Wang, S. S., Weerdenburg, H., Anderson, S., et al. (2023) · Transplant Infectious Disease · doi:10.1111/tid.14018 · Cited by 1
Ingham, A. C., Kielsen, K., Cilieborg, M. S., Lund, O., Holmes, S., Aarestrup, F. M., Müller, K., & Pamp, S. J. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/590893 · Cited by 1
Targeting the gut microbiome in allogeneic hematopoietic stem cell transplantationPreprint
de Leeuw, M. A., & Duval, M. X. (2020) · medRxiv · doi:10.1101/2020.04.08.20058198 · Cited by 1
Ingham, A. C., Kielsen, K., Mordhorst, H., Ifversen, M., Aarestrup, F. M., Müller, K., & Pamp, S. J. (2021) · Research Square · doi:10.21203/rs.3.rs-258775/v1 · Cited by 1
Tillotson, G. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737439922.793571921
Wingard, J. R., & Farhadfar, N. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.736117892.793563392
Taniguchi, K., Sawamura, H., Ikeda, Y., Tsuji, A., & Matsuda, S. (2022) · OBM Transplantation · doi:10.21926/obm.transplant.2203165
Rashidi, A., Peled, J. U., & Staley, C. M. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac888
Härter, J., & Silla, L. M. D. R. (2022) · JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY · doi:10.46765/2675-374x.2022v3n2p175
van Groningen, L. F. J., van Dorp, S., Bremmers, M. E. J., Fazel, S., Roeven, M. W. H., Blijlevens, N. M. A., & van der Velden, W. J. F. M. (2024) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2024.2331081
Olivetti, C. E., Fernández, M. F., Stojanova, J., Ruvinsky, S., Mangano, A. M., & Schaiquevich, P. S. (2024) · Methods and Protocols · doi:10.3390/mps7040064 · Cited by 1
Candidiasis in the Era of COVID-19: Challenges, Treatment Approaches, and Research Priorities
Mallick, U., Sahu, B. K., Ray, A., Hegde, R., & Sahu, M. C. (2026) · Current Biotechnology · doi:10.2174/0122115501427698260608072051
Lipan, L. E., Vihta, K.-D., Marcu, A. D., Avramescu, I., Jardan, D., Palade, A., Coliţă, A., Dima, S., Constantinescu, I., Iordan, I., et al. (2026) · GERMS · doi:10.3390/germs16030017
Microbiome-Based Therapeutics in Oncology: Expanding Indications Beyond C. difficile
Al-Omari, A., Kheshman, A., Morkos, P., Davanzo, K., & Monday, L. (2026) · Onco · doi:10.3390/onco6030047
Gruber, I., Edinger, M., Poeck, H., Meedt, E., Holler, E., Herr, W., Koelbl, O., Wolff, D., & Weber, D. (2026) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2026.09.037 · Cited by 1
Liu, S., Feng, Y.-W., & Zhu, C. (2026) · Transplant Immunology · doi:10.1016/j.trim.2026.102470
Metadata
- Authors
- Weber, D., Hiergeist, A., Weber, M., Dettmer, K., Wolff, D., Hahn, J., Herr, W., Gessner, A., & Holler, E.
- Affiliations
- University Hospital Regensburg (DE)
- Institute of Medical Microbiology and Hygiene (DE)
- University of Regensburg (DE)
- Corresponding author
- Weber, Daniela
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-08-17
- Volume
- 68
- Issue
- 8
- Pages
- 1303-1310
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2887939463
- Cited by
- 92
- References
- 42
- Citations by year
- 2026: 7 · 2025: 5 · 2024: 14 · 2023: 15 · 2022: 13 · 2021: 10 · 2020: 15 · 2019: 13
- FWCI
- 3.38
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- University of Regensburg Publication Server (University of Regensburg) (acceptedVersion)
- University of Regensburg Publication Server (University of Regensburg)
- Funders
- Jose Carreras Leukemia Foundation (DJCLS 01 GvHD/2016)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
- Keywords
- allogeneic stem cell transplantation, gut microbiota, broad-spectrum antibiotics, rifaximin, ciprofloxacin, metronidazole, indoxyl sulfate, gut microbiota diversity, gastrointestinal graft-versus-host disease, Clostridium cluster XIVa, antibiotic stewardship, non-relapse mortality, piperacillin-tazobactam
- MeSH terms
- Gastrointestinal Microbiome, Adult, Anti-Bacterial Agents, Graft vs Host Disease, Humans, Middle Aged, Retrospective Studies, Transplantation, Homologous, Hematopoietic Stem Cell Transplantation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.